William Blair has upgraded FibroGen Inc (NASDAQ:FGEN) from Market Perform To Outperform, citing a deep dive opportunity for its wholly owned monoclonal…
Morgan Stanley analyst Dara Mohsenian upgraded Colgate-Palmolive Company (NYSE:CL) from Equal-Weight to Overweight with a price target of $82. The analyst believes…